These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 10494443)
1. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Raskind MA; Peskind ER; Holmes C; Goldstein DS Biol Psychiatry; 1999 Sep; 46(6):756-65. PubMed ID: 10494443 [TBL] [Abstract][Full Text] [Related]
2. Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine. Peskind ER; Wingerson D; Murray S; Pascualy M; Dobie DJ; Le Corre P; Le Verge R; Veith RC; Raskind MA Arch Gen Psychiatry; 1995 Sep; 52(9):774-82. PubMed ID: 7654129 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients. Le Corre PA; Peskind ER; Chevanne F; Raskind MA; Le Verge R Eur J Clin Pharmacol; 1997; 52(2):135-8. PubMed ID: 9174683 [TBL] [Abstract][Full Text] [Related]
4. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Raskind MA; Peskind ER; Halter JB; Jimerson DC Arch Gen Psychiatry; 1984 Apr; 41(4):343-6. PubMed ID: 6703854 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats. Szemeredi K; Komoly S; Kopin IJ; Bagdy G; Keiser HR; Goldstein DS Brain Res; 1991 Feb; 542(1):8-14. PubMed ID: 2054662 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging. Peskind ER; Elrod R; Dobie DJ; Pascualy M; Petrie E; Jensen C; Brodkin K; Murray S; Veith RC; Raskind MA Neuropsychopharmacology; 1998 Dec; 19(6):465-71. PubMed ID: 9803422 [TBL] [Abstract][Full Text] [Related]
7. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. Goldstein DS; Eisenhofer G; Stull R; Folio CJ; Keiser HR; Kopin IJ J Clin Invest; 1988 Jan; 81(1):213-20. PubMed ID: 3335637 [TBL] [Abstract][Full Text] [Related]
8. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. Goldstein DS; Cannon RO; Quyyumi A; Chang P; Duncan M; Brush JE; Eisenhofer G J Auton Nerv Syst; 1991 Jun; 34(1):17-35. PubMed ID: 1940014 [TBL] [Abstract][Full Text] [Related]
9. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats. Tjurmina OA; Goldstein DS; Palkovits M; Kopin IJ Brain Res; 1999 May; 826(2):243-52. PubMed ID: 10224302 [TBL] [Abstract][Full Text] [Related]
10. Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans. Peskind ER; Veith RC; Dorsa DM; Gumbrecht G; Raskind MA Neuroendocrinology; 1989 Sep; 50(3):286-91. PubMed ID: 2552342 [TBL] [Abstract][Full Text] [Related]
11. Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats. Szemeredi K; Stull R; Kopin IJ; Goldstein DS Eur J Pharmacol; 1989 Oct; 170(1-2):53-9. PubMed ID: 2575527 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of catechols during reflexive changes in sympathetic nerve activity. Garty M; Deka-Starosta A; Chang PC; Eisenhofer G; Zukowska-Grojec Z; Stull R; Kopin IJ; Goldstein DS Neurochem Res; 1989 Jun; 14(6):523-31. PubMed ID: 2503766 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension. Goldstein DS; Holmes C; Patronas N; Kopin IJ Clin Sci (Lond); 2003 Jun; 104(6):649-54. PubMed ID: 12540289 [TBL] [Abstract][Full Text] [Related]
19. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Elrod R; Peskind ER; DiGiacomo L; Brodkin KI; Veith RC; Raskind MA Am J Psychiatry; 1997 Jan; 154(1):25-30. PubMed ID: 8988954 [TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic/pharmacodynamic investigation: assessment of edivoxetine and atomoxetine on systemic and central 3,4-dihydroxyphenylglycol, a biochemical marker for norepinephrine transporter inhibition. Kielbasa W; Pan A; Pereira A Eur Neuropsychopharmacol; 2015 Mar; 25(3):377-85. PubMed ID: 25637266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]